The Alzheimer’s Disease Data Initiative (ADDI) is on a mission to fundamentally transform Alzheimer’s disease (AD) research. Through a data sharing platform, data science tools, funding opportunities, and global collaborations, ADDI is advancing scientific breakthroughs and accelerating progress towards new treatments and cures for AD and related dementias.

Our Partners

To accelerate the development of new and more effective treatments for AD, ADDI's partners are working together to build better tools to help the brightest minds around the world access, use, and share dementia-related data.

Today, nearly 50 million people worldwide have AD or related dementias. Researchers estimate that the cost to treat these patients is more than $800 billion per year. And as the world’s elderly population grows, the number of dementia patients worldwide and the disease’s financial cost will increase as well. Yet, we still lack therapies that can slow or reverse its course. These costs are already squeezing healthcare budgets in developed countries. If they aren’t addressed, the burden placed on health systems around the world will be debilitating.

That’s why, in 2018, Bill Gates and a coalition of partners decided to look beyond the divisions of disciplines, borders, and university walls and work together to improve the Alzheimer’s disease and related dementias data ecosystem.

Gates  Notes
Posted November 17, 2020
Quote Mark

I’m optimistic that this will make a real difference in Alzheimer’s research, because there are many examples where we’ve made progress on diseases after bringing together large amounts of data.